Actos® and Bladder Cancer: An Increased Risk of 40%
Did you take Actos® to treat type 2 diabetes mellitus and later develop bladder cancer? You may be entitled to compensation.
According to the U.S. Food and Drug Administration (FDA), patients took the diabetes drug Actos (pioglitazone) may have a 40 percent increased risk of contracting bladder cancer. Since the discovery, the manufacturer has updated the warning labels for pioglitazone-containing medicines to reflect their potential association to cancer, but unfortunately, that warning comes too late for many medication users.
If you or someone you love has taken Actos, developed bladder cancer, and is a non-smoker, our staff of experienced legal professionals may be able to help. Complete a free initial consultation form or dial (800) 996-0911 to get answers today.